ChengDu ShengNuo Biotec Co.,Ltd. (SHA:688117)

ChengDu ShengNuo Biotec Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	801.4	741.46	456.07	435.02	395.72	386.53
Revenue Growth	49.42%	62.58%	4.84%	9.93%	2.38%	2.05%
Gross Profit Gross Profit Growth	455.42	412.59	253.23	271.64	253.33	275.86
Operating Income Operating Income Growth	233.07	210.63	66.06	77.27	65.04	65.71
Net Income Net Income Growth	177.17	157.92	50.02	70.34	64.48	61.25
Earnings Per Share EPS Growth	0.80	0.71	0.23	0.32	0.30	0.31
EPS Growth	118.17%	212.47%	-27.73%	6.89%	-4.49%	-14.98%

Revenue by Segment

Chart

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023
Active Pharmaceutical Ingredient (API) Active Pharmaceutical Ingredient (API) Growth	408.73	154.78	119.41
Preparations Preparations Growth	196.61	189.37	176.71
Pharmaceutical Research Services Pharmaceutical Research Services Growth	89.68	60.92	92.33
Customized Production Customized Production Growth	23.33	26.24	11.09
Technology Transfer Technology Transfer Growth	16.98	-	-
Consignment Processing Services Consignment Processing Services Growth	0.05	19.78	31.79
Unallocated Others Unallocated Others Growth	5.59	4.78	3.7
Total Total Growth	740.96	455.86	435.02

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	297.72	301.3	238.86	269.13	372.12	411.56
Total Debt Total Debt Growth	576.43	589.67	482.42	261.7	102.64	32.89
Net Cash (Debt) Net Cash Growth	-278.7	-288.37	-243.56	7.43	269.48	378.68
Net Cash Growth	-	-	-	-97.24%	-28.84%	192.35%
Net Cash Per Share Net Cash Per Share Growth	-1.26	-1.30	-1.11	0.03	1.24	1.92

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	147.56	178.45	25.27	84.78	95.62	52.41
Capital Expenditures CapEx Growth	-132.28	-145.77	-247.48	-277.98	-135.85	-64.22
Free Cash Flow Free Cash Flow Growth	15.28	32.68	-222.2	-193.2	-40.23	-11.81
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	56.83%	55.65%	55.52%	62.44%	64.02%	71.37%
Operating Margin	29.08%	28.41%	14.49%	17.76%	16.44%	17.00%
Pretax Margin	26.15%	25.51%	13.49%	18.42%	18.29%	18.24%
Profit Margin	22.11%	21.30%	10.97%	16.17%	16.30%	15.85%
FCF Margin	1.91%	4.41%	-48.72%	-44.41%	-10.17%	-3.06%

Dividends

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 29, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Dividend Per Share Dividend Per Share Growth	0.251	0.251	0.071	0.102	0.091	0.109
Dividend Per Share Growth	242.69%	251.96%	-30.00%	11.96%	-16.65%	-
Dividend Yield	1.08%	0.94%	0.55%	0.72%	1.16%	0.85%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 29, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	28.93	37.66	57.69	44.90	27.57	47.82
Forward PE	24.74	23.96	20.17	24.79	-	-
P/FCF Ratio	333.87	182.00	-	-	-	-
PS Ratio	6.36	8.02	6.33	7.26	4.49	7.58

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 26, 2026

Data Sources Report a data error